These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32241595)

  • 1. De-escalation towards omission is the tipping point of individualizing breast cancer surgery.
    Heil J; Pfob A; Kuerer HM
    Eur J Surg Oncol; 2020 Aug; 46(8):1543-1545. PubMed ID: 32241595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients should be the tipping point of individualizing breast cancer surgery: Commentary on 'Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges'.
    Heil J; Pfob A
    Ann Oncol; 2020 Sep; 31(9):1264. PubMed ID: 32473970
    [No Abstract]   [Full Text] [Related]  

  • 3. A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006).
    Gharzai LA; Szczygiel LA; Shumway DA; Bandos H; Julian TB; Mamounas EP; White J; De Los Santos JF; Basik M; Ganz PA; Jagsi R
    Breast Cancer Res Treat; 2021 Jun; 187(3):777-784. PubMed ID: 33740205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of various surgical methods in the treatment of breast cancer].
    Irov NN
    Khirurgiia (Mosk); 1989 May; (5):17-9. PubMed ID: 2739326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omission of Breast Surgery in Exceptional Responders.
    Tasoulis MK; Lee HB; Kuerer HM
    Clin Breast Cancer; 2024 Jun; 24(4):310-318. PubMed ID: 38365541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early breast cancer: concept and therapeutic review.
    Bastos MCS; Almeida AP; Bagnoli F; Oliveira VM
    Rev Assoc Med Bras (1992); 2023; 69(suppl 1):e2023S114. PubMed ID: 37556633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary surgery in the treatment of invasive cancers of the breast].
    Laffargue F; Giacalone PL
    Ann Chir Plast Esthet; 1992 Dec; 37(6):646-51. PubMed ID: 1340168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A personal experience with Halsted's radical mastectomy.
    Haagensen CD; Bodian C
    Ann Surg; 1984 Feb; 199(2):143-50. PubMed ID: 6696529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive Operations.
    Ollila DW; Hwang ES; Brenin DR; Kuerer HM; Yao K; Feldman S
    Ann Surg Oncol; 2018 Oct; 25(10):2807-2812. PubMed ID: 29968033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey.
    Caballero C; Lundon DJ; Vasileva-Slaveva M; Montagna G; Bonci EA; Brandl A; Smith H; Kok JHH; Holmberg CJ; Sayyed R; Santrac N; Suppan I; Kaul P; Vassos N; Lorenzon L; Murphy M; Ceelen W; de Azambuja E; McIntosh SA; Rubio IT
    Eur J Surg Oncol; 2024 Oct; 50(10):108585. PubMed ID: 39146663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pleural metastases of breast cancer in patients operated with Halsted's method (radical mastectomy)].
    Malska-Waniewska I; Hankiewicz J
    Pol Tyg Lek; 1966 May; 21(22):839-41. PubMed ID: 5962182
    [No Abstract]   [Full Text] [Related]  

  • 12. Artificial intelligence to de-escalate loco-regional breast cancer treatment.
    Pfob A; Heil J
    Breast; 2023 Apr; 68():201-204. PubMed ID: 36842193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence.
    Su Y; Guo R; Xue J; Chi Y; Chi W; Wang J; Yang B; Wu J
    Oncologist; 2019 Sep; 24(9):e818-e827. PubMed ID: 30842240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-escalation of Axillary Surgery in the Neoadjuvant Chemotherapy (NACT) Setting for Breast Cancer: Is it Oncologically Safe?
    Wazir U; Mokbel K
    Anticancer Res; 2020 Oct; 40(10):5351-5354. PubMed ID: 32988853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omitting surgery for early breast cancer showing clinical complete response to primary systemic therapy.
    Shigematsu H; Fujisawa T; Shien T; Iwata H
    Jpn J Clin Oncol; 2020 Jun; 50(6):629-634. PubMed ID: 32378709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [History of breast cancer surgery and its perspectives].
    Tajima T
    Nihon Geka Gakkai Zasshi; 2000 Dec; 101(12):833-9. PubMed ID: 11201110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery. Preliminary results.
    Komoike Y; Motomura K; Inaji H; Kasugai T; Koyama H
    Oncology; 2003; 64(1):1-6. PubMed ID: 12457024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assessment of neoadjuvant therapy use in breast conservation: barriers to implementation.
    James T; McCahill L; Ratliff J; Ashikaga T; Single R; Sheehey-Jones J; Messier N; Stanley M; Krag D; Harlow S
    Breast J; 2009; 15(5):524-6. PubMed ID: 19624412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The history of mastectomy.
    Loukas M; Tubbs RS; Mirzayan N; Shirak M; Steinberg A; Shoja MM
    Am Surg; 2011 May; 77(5):566-71. PubMed ID: 21679589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.